Featured Content

Agency Approves Drug for Adult ADHD 8/19/2008

The FDA has broadened the indications for methylphenidate (Concerta) extended-release tablets in doses of 18 mg to 72 mg/day to include adults with attention-deficit hyperactivity disorder (ADHD).

Related Content

Acute Pancreatitis: Risks, Causes, and Mortality in Older Adults

In the elderly, acute pancreatitis is most commonly caused by gallstones, is more likely to be severe, and is associated with higher mortality. 



Counseling Patients With Hemorrhoids

Many patients who initially seek relief through the use of nonprescription products will require referral to a physician. 

Disorders Associated With Celiac Disease

With celiac disease, the risk of developing other autoimmune and nonautoimmune disorders increases.

Pharmaceutical Care of Celiac Disease

Celiac disease, also known as gluten-sensitive enteropathy or sprue, is a chronic autoimmune disorder caused by a genetic intolerance to gluten.

Advising Patients With Acne

Benzoyl peroxide and salicylic acid are among the OTC products found effective. 

ADHD

FDA Fast Facts 3/21/2007

Xolair to Get Black Box Warning The FDA requested that Genentech, Inc.

Advertisement